ReFlections

Add a title
#F2F2F2
NaN
true
false
Pipe Position
Image
Medical
  • Publications
  • May 2016
  • 30 minutes

ReFlections Volume 38, Spring 2016

By
  • Dr. Sheetal Salgaonkar
  • Dr. Heather M. Lund
Skip to Authors and Experts
chronic lymphocytic leukemia
In Brief
Review the role of genetics in chronic lymphocytic leukemia and explore Cancer Reimbursement products.

This edition contains two very timely articles. The science of genetics is becoming an increasingly important element in both the diagnosis and treatment of many disease conditions. In the first article, Dr. Sheetal Salgoankar, Medical Director, India, provides an in-depth review of the role of genetics in the rapidly-changing diagnostic criteria, risk stratification, and treatment of individuals with chronic lymphocytic leukemia (CLL).

In the second article, Dr. Heather Lund, Chief Medical Officer – Asia, discusses the relatively new but increasingly popular Cancer Reimbursement product and its design, underwriting and claims issues.

We are confident you will find both of these articles informative and that they will enrich your knowledge of insurance medicine. ReCite, our medical literature review section, has also been updated with several recently published and relevant articles of interest to both underwriters and medical directors. Finally, The Longer Life Foundation remains actively engaged in its research function. Our update provides information about groundbreaking research on obesity conducted by an LLF-supported investigator who is also a member of the foundation’s advisory committee.

Chronic Lymphocytic Leukemia: An Update
Cancer Reimbursement: A Niche Solution
A physician analyzing a case
Explore the Full Magazine

More Like This...

Meet the Authors & Experts

Dr. Sheetal Salgaonkar
Author
Dr. Sheetal Salgaonkar
Vice President and Medical Director, Global Medical
Dr. Heather Lund
Author
Dr. Heather M. Lund
Regional Chief Medical Officer, RGA Asia
Medical
  • Publications
  • May 2016
  • 30 minutes

ReFlections Volume 38, Spring 2016

By
  • Dr. Sheetal Salgaonkar
  • Dr. Heather M. Lund
Skip to Authors and Experts
chronic lymphocytic leukemia
In Brief
Review the role of genetics in chronic lymphocytic leukemia and explore Cancer Reimbursement products.

This edition contains two very timely articles. The science of genetics is becoming an increasingly important element in both the diagnosis and treatment of many disease conditions. In the first article, Dr. Sheetal Salgoankar, Medical Director, India, provides an in-depth review of the role of genetics in the rapidly-changing diagnostic criteria, risk stratification, and treatment of individuals with chronic lymphocytic leukemia (CLL).

In the second article, Dr. Heather Lund, Chief Medical Officer – Asia, discusses the relatively new but increasingly popular Cancer Reimbursement product and its design, underwriting and claims issues.

We are confident you will find both of these articles informative and that they will enrich your knowledge of insurance medicine. ReCite, our medical literature review section, has also been updated with several recently published and relevant articles of interest to both underwriters and medical directors. Finally, The Longer Life Foundation remains actively engaged in its research function. Our update provides information about groundbreaking research on obesity conducted by an LLF-supported investigator who is also a member of the foundation’s advisory committee.

Chronic Lymphocytic Leukemia: An Update
Cancer Reimbursement: A Niche Solution
A physician analyzing a case
Explore the Full Magazine

More Like This...

Meet the Authors & Experts

Dr. Sheetal Salgaonkar
Author
Dr. Sheetal Salgaonkar
Vice President and Medical Director, Global Medical
Dr. Heather Lund
Author
Dr. Heather M. Lund
Regional Chief Medical Officer, RGA Asia